$0.80
+0.04 (+5.30%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,259.2% upside
Low Target
$7.63
Average Target
$10.81
High Target
$13.89
Current Price
$0.80
Current
$0.80
$0.80
Target
$10.81
$10.81
$7.63
$10.81 avg
$13.89
Scenario Analysis
Bear Case
$7.63
859.4%
Low target
Base Case
$10.81
+1,259.2%
Avg target
Bull Case
$13.89
+1,646.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.31
-76.0% from high
52-Week Low
$0.72
+10.4% from low
Target vs 52W High
$10.81
+226.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |